Wednesday 6 April | |
Applied Graphene Materials PLC | Half Year Results |
Gresham House Energy Storage Fund PLC | Full Year Results |
Hilton Food Group PLC | Full Year Results |
Hyve Group PLC | Trading Statement |
Topps Tiles PLC | Trading Statement |
Wentworth Resources PLC | Full Year Results |
Thursday 7 April | |
Alpha Financial Markets Consulting PLC | Trading Statement |
Attraqt Group PLC | Full Year Results |
Entain PLC | Q1 Results |
Robert Walters PLC | Q1 Results |
Tracsis PLC | Half Year Results |
Friday 8 April | |
CMC Markets PLC | Trading Statement |
Ferrexpo PLC | Trading Statement |
Monday 11 April | |
Tortilla Mexican Grill PLC | Full Year Results |
Sirius Real Estate Ltd | Trading Statement |
Tuesday 12 April | |
ASOS PLC | Half Year Results |
Cambridge Cognition Holdings PLC | Full Year Results |
Destiny Pharma PLC | Full Year Results |
easyJet PLC | Trading Statement |
Filta Group Holdings PLC | Full Year Results |
JD Sports Fashion PLC | Full Year Results |
Liontrust Asset Management | Trading Statement |
M Winkworth PLC | Full Year Results |
Moneysupermarket.com Group PLC | Trading Statement |
Nanoco Group PLC | Half Year Results |
Pennon Group PLC | Trading Statement |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
Cambridge Cognition hoping to ride coat-tails of Biogen Alzheimer's programme
(Sharecast News) - Cambridge Cognition announced on Friday that, Following a consultation with the US Food and Drug Administration (FDA), Biogen and Eisai have announced plans to pursue regulatory approval for 'aducanumab', which would be the first therapy to tackle clinical decline in early Alzheimer's disease.
Read more